DENTSPLY SIRONA (XRAY) vs. Remedent (OTCMKTS:REMI) Head-To-Head Comparison
DENTSPLY SIRONA (NASDAQ:XRAY) and Remedent (OTCMKTS:REMI) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.
This table compares DENTSPLY SIRONA and Remedent’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
DENTSPLY SIRONA pays an annual dividend of $0.35 per share and has a dividend yield of 1.0%. Remedent does not pay a dividend. DENTSPLY SIRONA pays out 13.2% of its earnings in the form of a dividend. DENTSPLY SIRONA has increased its dividend for 6 consecutive years.
This is a breakdown of current recommendations and price targets for DENTSPLY SIRONA and Remedent, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
DENTSPLY SIRONA currently has a consensus target price of $52.18, indicating a potential upside of 45.47%. Given DENTSPLY SIRONA’s higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Remedent.
Insider & Institutional Ownership
97.6% of DENTSPLY SIRONA shares are owned by institutional investors. 1.9% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares DENTSPLY SIRONA and Remedent’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|DENTSPLY SIRONA||$3.99 billion||2.00||-$1.55 billion||$2.66||13.48|
Remedent has lower revenue, but higher earnings than DENTSPLY SIRONA.
Risk & Volatility
DENTSPLY SIRONA has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Remedent has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500.
DENTSPLY SIRONA beats Remedent on 12 of the 15 factors compared between the two stocks.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth leaving the patient's healthy tooth structure intact. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. It sells its products to dental professionals in approximately 30 countries, including Europe, Asia, Latin America, the Pacific Rim, the Middle East, and the United States through dealers, as well as directly to the consumers through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.